Post-earnings recap
Reported
Tue, Jan 30, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Zimmer Biomet's earnings report shows a slight miss on EPS, which contributed to a 1.14% decline in stock price. The lack of revenue data and forward guidance may leave investors uncertain about the company's near-term outlook. Management's focus on operational improvements suggests they are working to address current challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.10 | N/A | -0.37% |
Management acknowledged the challenges faced in the quarter. They emphasized ongoing efforts to enhance operational efficiency.
Management did not provide specific guidance for future performance.
The company remains focused on operational improvements.